After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
BDTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Black Diamond Therapeutics Inc is $94.65M. A total of 0.58 million shares were traded on the day, compared to an average of 3.25M shares.
In the most recent transaction, BIOTECH GROWTH N V sold 5,784,292 shares of BDTX for 2.07 per share on Mar 19 ’25. After the transaction, the 10% Owner now owns 2,733,547 company shares. In a previous transaction on Aug 28 ’24, Versant Venture Capital VI, L. sold 221,600 shares at 6.32 per share. BDTX shares that 10% Owner owns now total 3,726,341.
Among the insiders who bought shares, David Epstein acquired of 50,000 shares on Jul 31 ’24 at a per-share price of $6.20. In another insider transaction, David Epstein bought 50,000 shares at $6.20 per share on Jul 26 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BDTX has a high of $7.66 and a low of $1.20.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BDTX’s latest balance sheet shows that the firm has $209.79M in Cash & Short Term Investments as of fiscal 2021. There were $28.46M in debt and $23.64M in liabilities at the time. Its Book Value Per Share was $1.47, while its Total Shareholder’s Equity was $195.90M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDTX is Buy with a score of 4.80.
